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Keratin 10 (K10) is the major protein in the upper epidermis where it maintains keratinocyte integrity. Others have
reported that K10 may act as a tumor suppressor upon ectopic expression in mice. Although K10/ mice show
significant epidermal hyperproliferation, accompanied by an activation of the mitogen-activated protein kinase
(MAPK) pathway, they formed no spontaneous tumors. Here, we report that K10/ mice treated with 7,12-dime-
thylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA) developed far less papillomas than
wild-type mice. BrdU(5-bromo-20-deoxyuridine)-labeling revealed a strongly accelerated keratinocyte turnover in
K10/ epidermis suggesting an increased elimination of initiated keratinocytes at early stages of developing
tumors. This is further supported by the absence of label-retaining cells 18 d after the pulse whereas in wild-type
mice label-retaining cells were still present. The concomitant increase in K6, K16, and K17 in K10 null epidermis and
the increased motility of keratinocytes is in agreement with the pliability versus resilience hypothesis, stating that
K10 and K1 render cells more stable and static. The K10/ knockout represent the ﬁrst mouse model showing
that loss of a keratin, a cytoskeletal protein, reduces tumor formation. This is probably caused by an accelerated
turnover of keratinocytes, possibly mediated by activation of MAPK pathways.
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Keratin 10 (K10) and its partner K1 are the major structural
proteins of the epidermis and belong to the large family of
intermediate filament (IF) proteins (Hesse et al, 2001, 2004;
Herrmann et al, 2003). Depending on their differentiation
state, keratinocytes express different sets of keratins (Cou-
lombe and Omary, 2002).
The epidermis is a stratified epithelium that regenerates
permanently from the basal layer. The basal layer contains
K14, K15, and K5, whereas suprabasal, postmitotic cells
switch to the expression of K1 and K10 and minor amounts
of K2e and K9. Under conditions of altered differentiation,
like wound healing or in tumors, K6, K16, and K17 are in-
duced, whereas the expression of K10 and K1 is sup-
pressed (Roop et al, 1988; McGowan and Coulombe, 1998;
Mazzalupo et al, 2003). The functional consequences of
these adaptations are not completely understood, but some
data indicated that individual keratins confer distinct prop-
erties to the respective IF cytoskeleton: activated keratin-
ocytes involved in wound closure appear to rely on a more
dynamic keratin filament system containing K6, K16, and
K17 (Wawersik and Coulombe, 2000; Mazzalupo et al, 2003)
and K10/K1 filaments are supposed to have intrinsic bun-
dling properties and may be less dynamic, which might be
a prerequisite for a more rigid cell architecture (Eichner
and Kahn, 1990; Blessing et al, 1993; Reichelt et al, 2001;
Coulombe and Omary, 2002).
The observation that the expression of K10 is restricted
to postmitotic cells and the fact that its expression is down-
regulated in skin tumors (Winter et al, 1983; Roop et al,
1988) led to the hypothesis that K10 might be involved in the
control of cell proliferation. Results from cell transfection
experiments indicated a direct role for K10 in inhibiting cell
cycle entry by sequestering Akt kinase (Paramio et al, 2001).
In this cell culture system, the K10-induced inhibition of the
cell cycle was found to depend on the retinoblastoma (Rb)
protein (Paramio et al, 1999). The same authors then re-
ported that ectopic expression of K10 in the basal epider-
mal layer of transgenic mice led to a strong decrease in
proliferation and reduced tumorigenesis (Santos et al, 2002)
lending further support to a role of K10 in cell cycle control.
In contrast, ectopic expression of transgenic K10 in the
pancreas was compatible without changes in cell prolifer-
ation (Blessing et al, 1993).
The knockout of K10 in mice enabled us to address the
effect of its loss in its authentic compartment. Here, sup-
rabasal K10 loss did not lead to an induction of proliferation
but stimulated another keratinocyte population, residing in
the basal cell layer, to hyperproliferate. This increased basal
cell proliferation was accompanied by higher levels of c-
Abbreviations: DMBA, 7,12-dimethylbenz[a]anthracene; K, keratin;
MAPK, mitogen-activated protein kinase; Rb, retinoblastoma; TPA,
D12-O-tetradecanoylphorbol-13-acetate
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Myc and cyclin D1 but did not lead to spontaneous tumor
formation (Reichelt and Magin, 2002). In order to investigate
whether an additional challenge would reveal an increased
susceptibility to tumor development, we subjected these
mice to experimental skin carcinogenesis.
The two-step experimental skin carcinogenesis protocol
is a well-established approach to investigate tumor for-
mation (Yuspa, 1998; Perez-Losada and Balmain, 2003).
A single application of 7,12-dimethylbenz[a]anthracene
(DMBA) initiates tumor formation by introducing Ras-acti-
vating mutations and subsequent repeated application of
the phorbol ester 12-O-tetradecanoylphorbol-13-acetate
(TPA) promotes tumor development (Balmain et al, 1984;
Quintanilla et al, 1986). Active Ras stimulates a magnitude
of downstream cascades (Shields et al, 2000). After a few
weeks, papillomas develop, some of which finally progress
to squamous cell carcinomas. The activated Ras induces
mitogen-activated protein kinase (MAPK) signaling, which
alters the differentiation program of the affected cells. The
altered epidermal differentiation of the benign papillomas is
reflected by increased proliferation and by the distinct ex-
pression pattern of keratins. K10 and K1 are downregulat-
ed, whereas K6 and K16 expressions, as well as those of K4
and K13, usually restricted to the stratified epithelia of the
esophagus and forestomach, are induced (Nischt et al,
1988; Roop et al, 1988).
Here, we used experimental skin carcinogenesis to as-
sess whether K10/ epidermis, which shows basal cell
hyperproliferation as a consequence of the knockout, has
an altered susceptibility to the development of tumors.
Results
Reduced papilloma formation upon two-step experi-
mental skin carcinogenesis in K10/mice Following the
ectopic expression of K10 in the basal epidermis, Santos
et al (2002) have noted that tumor formation upon chemical
carcinogenesis was delayed. Here, we analyzed the loss of
K10 in its natural compartment, namely the suprabasal
epidermal layer. K10/ mice, although showing basal cell
hyperproliferation, did not develop tumors spontaneously.
In order to investigate whether challenging the skin of these
mice may reveal a higher susceptibility to tumor develop-
ment, we applied the well-established two-step experimen-
tal skin carcinogenesis protocol. Most importantly, there
was a decrease in papilloma formation in K10/ mice
compared to controls (Fig 1). At the end of the experiment,
after 40 wk of repeated TPA application, the tumor yield was
at three tumors per knockout animal, whereas the controls
carried 9 tumors on average per animal (Fig 1a). Palpable
tumors appeared 13 wk after the initial DMBA application in
some individuals of both genotypes. The tumor incidence
was comparable between wild-type and K10/ mice (Fig
1b). Size, morphology and histological analysis indicated
that papillomas were equal in both groups (representative
section of a wild-type papilloma in Fig 8a). The progression
of papillomas to squamous cell carcinomas was indistin-
guishable in both groups.
In previous experiments, we carried out treatments with
three different dosages of DMBA, namely 1, 10, and 100
nmol followed by 10 nmol TPA application for 18 wk. Under
these conditions, tumor incidences were 63%, 93%, and
100% and tumor multiplicities were 1.1, 6.7, and 8.5, re-
spectively. This demonstrates that a 10-fold reduction in
DMBA concentration results in nearly the same effects.
Therefore, with the dose of DMBA we used here, the car-
cinogen is not limited in the basal epidermal layers of the
two genotypes of mice.
In order to test whether the proliferative response of
K10/ mice towards TPA treatment was comparable to
that of wild-type mice, we analyzed BrdU-uptake after the
application of TPA to the skin of the inner aspect of the ear.
We found a mild effect in both genotypes using 0.25 nmol
(Fig 2a, b) and a strong induction of proliferation using 0.5
nmol TPA (Fig 2c, d ) at 24 h after the application of the drug.
At the lower TPA dose, scoring of BrdU-labeled nuclei of
basal and suprabasal layers showed a higher proliferation
index in K10/ mice than in wild-type mice (Table I). A
strong increase in basal and suprabasal proliferation was
observed in both genotypes at a higher TPA dose (0.5
nmol). The amount of proliferating basal cells was compa-
rable in both genotypes, whereas proliferation of apparent
suprabasal cells was stronger in the knockout (Table I).
As K10/ mice showed hyperproliferation of basal
Figure1
Induction of tumor development in wild-type and K10/ mice
along the initiation-promotion protocol of mouse skin carcinogen-
esis. The animals received weekly applications of 5 nmol TPA after an
initial treatment with DMBA. Tumor yield (a) and incidence (b) were
plotted against time. K10/ papillomas are represented by black
squares and the wild-type by open squares.
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keratinocytes as a consequence of the knockout (Fig 3a, b),
the comparison of TPA-treated skin of these mice with wild-
type mice is not straightforward. Although it is not possible
to distinguish between proliferation caused by the lack of
K10 and proliferation caused by TPA in K10/ epidermis,
the experiment demonstrates that both groups of mice re-
acted with a strong proliferation increase.
Accelerated cell turnover of K10/ epidermis Hyper-
proliferation was accompanied by an increased epidermal
cell turnover in K10/ mice which became evident by trac-
ing the fate of BrdU-pulse-labeled cells over a period of 18 d
in ear (Fig 3) and back skin (not shown). Two hours after the
pulse, K10/ epidermis showed about eight times more
labeled cells than the wild-type (Fig 3a, b and Table II).
Whereas at that time point almost exclusively basal cells
were labeled, 24 h later basal cells had proliferated and
given rise to twice the amount of labeled basal cells plus the
same amount of suprabasal cells (Fig 3c, d). Accordingly,
cell cycle time of actively proliferating keratinocytes was
reduced to less than 24 h in the knockout. The accelerated
transit time was clearly notable at 3 d after the pulse (Fig 3e,
f) when BrdU-labeled cells had reached the granular layer in
the knockout, although the labeled cells of the wild-type
were still connected to the basement membrane and had
divided 1–2 times (Table II). Those cells which were still lo-
cated in the basal layer in knockout mice showed a strongly
reduced amount of label, indicating that they had divided
more than once. The number of labeled nuclei was highest
at the third day of the experiment suggesting that shortly
thereafter but before the fifth day, labeled nuclei had
reached the cornified layer where they were degraded and
eventually shed (Table II). The dilution of BrdU continued in
the course of time (Fig 3k), and 9 d after the pulse, no ho-
mogeneously labeled, but nuclei containing small dots of
label were detectable (Fig 3m) indicating that the cells
had divided at least 5 times. Interestingly, 18 d after the
pulse no labeled cell, not even in the bulge region of hair
follicles, was left in K10/ skin, in contrast to the wild-type
(Fig 3n, o).
Based on these data, we suggest a model for the pro-
liferation and transition behavior of basal epidermal cells
in K10/ mice. The experiment demonstrated that the
transition time was highly accelerated in K10/ epidermis
and that keratinocytes, once they had left the basement
membrane, reached the stratum corneum within 3–5 d
without additional cell divisions (Fig 3p, q). Whereas the
nuclei of these cells were homogeneously labeled, those
still connected to the basement membrane showed spotty
label residues (Fig 3q–s).
We conclude from our data that the accelerated turnover
results in an increased loss of initiated cells in DMBA/TPA-
treated K10/ mice which in turn leads to the reduced
tumor numbers we observed in knockout in comparison to
wild-type mice.
Altered localization of a6-integrin in K10
/ epidermis In
order to elucidate the molecular basis for the increased
keratinocyte transit through the tissue, we analyzed the ex-
pression of major adhesion proteins in the epidermis. We
detected some punctate a6-integrin staining in suprabasal
layers of K10/ epidermis whereas its expression is nor-
mally restricted to the basal membrane of basal keratin-
ocytes in the wild-type (Fig 4a, b). The distribution of the
adherens junction components E-cadherin (Fig 4c, d) and b-
catenin (Fig 4e, f ) was indistinguishable in both genotypes.
In addition, b-catenin was never detected in nuclei. Des-
moplakin (Fig 4g, h), a plakin family member that links IF to
desmosomes (Leung et al, 2002), plakoglobin (Fig 4i, k), as
well as the cytoskeletal linker protein plectin (Fig 4l, m) were
localized at the same sites in both wild-type and K10/
mice.
The absence of K10 modulates MAPK signaling In order
to explain the hyperproliferation of the basal cells in K10/
epidermis, we had proposed that the absence of K10 in
suprabasal cells initiated a signaling cascade resulting in
increased proliferation in basal keratinocytes (Reichelt and
Magin, 2002). Therefore, we investigated MAPK signaling.
Western blotting using phosphorylation specific antisera
against effectors in the MAP signaling pathway revealed
how this increase in proliferation is probably caused. The
loss of K10 induced the activation of the MAPK ERK1/2 and
p38 (Fig 5). ERK is known to be localized in basal keratin-
ocytes, whereas p38 is expressed in suprabasal layers
Table I. Cutaneous proliferative response to TPA
TPA (nmol)
BrdU-labeled nuclei/100 basal nuclei
Wild-type K10/
Basal Suprabasal Basal Suprabasal
Control 2.8  1.6 0  0 21.8  5.4 1.3  1.8
0.25 5.4  2.2 0  0 34.4  4.6 23.8  7.8
0.50 42.7  4.4 19.2  9.1 38.9  5.6 34.5  9.5
Mice received BrdU 24 h after TPA application on the inner ear surface.
They were sacrificed two hours later. BrdU-labeled nuclei were counted in
ear sections. 10–20 areas of 100 basal cells were scored respectively,
mean  SD are given.
TPA, 12-O-tetradecanoylphorbol-13-acetate.
Figure 2
TPA-mediated cell proliferation. BrdU-labeling 24 h after the appli-
cation of 0.25 nmol TPA to the ear skin revealed an obvious proliferative
response in both wild-type (a) and K10/ epidermis (b). At a higher
dose of the drug (0.5 nmol TPA) proliferation was strongly induced to a
comparable amount in basal as well as suprabasal layers of wild-type
(c) and K10/ epidermis (d). See Table I for statistical evaluation. Scale
bar¼ 40 mM; HF, hair follicle.
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of the epidermis (Takahashi et al, 2002). As expected,
activated p38 was hence found in all suprabasal layers in
K10/ mice and in higher amounts in the upper epidermis
(Fig 5c). The activation of ERK1/2 signaling serves as an
explanation of the observed hyperproliferation and possibly
of the increased turnover of K10/ epidermis. In pap-
illomas of both, K10/ and wild-type mice, ERK1/2 and
p38 were equally activated (not shown).
Figure3
Transition time increase of K10/ epi-
dermal keratinocytes. BrdU-label trac-
ing revealed that the exit of keratinocytes
from the basal layer was accelerated.
The images represent ear skin from mice
sacrificed 2 h (a, b), 1 d (c, d), 3 d (e, f), 5
d (g, h), 7 d (i, k), 9 d (l, m), and 18 d (n, o)
after BrdU injection. The left series of
images shows representative sections of
wild-type, and the right series shows skin
sections from K10/ mice. In the wild-
type few cells are initially labeled (a)
which give rise to a limited number of
daughter cells (c, e, g, i, l, n). Two hours
after the BrdU-pulse, exclusively basal
keratinocytes were labeled in K10/
skin (b). 24 h after labeling, suprabasal
cells were also labeled in the knockout
(d). Three days after the pulse, strongly
labeled cells were detected in the upper
granular layer. Nine days after the exper-
imental start, the label of the basal layer
and lower suprabasal layers were mark-
edly reduced (m) and 18 d after the
BrdU-pulse no label was left in K10/
epidermis (o), whereas some labeled
cells were still found in the wild-type (n).
We propose a model of proliferation and
transition of basal K10/ keratinocytes
(p–s). In (p) the observed fates of a BrdU-
pulse labeled basal K10/ cell are de-
picted. (1) A labeled cell migrates to the
upper epidermis without further division.
This is illustrated in the strongly stained
suprabasal nuclei in ear skin fixed 3 d
after a BrdU-pulse (q). (2) A labeled basal
cell divides in the basal compartment
before some daughter cells leave the ba-
sal membrane, followed after a lag peri-
od by their sisters, which is frequently
seen 7 d after a BrdU-pulse where nuclei
exhibit mostly diluted label (r). (3) The
labeled cell divides up to 5–6 times in the
basal layer before its daughters leave this
compartment and migrate to the skin
surface as observed in sections obtained
9 d after the pulse (s). See Table II for
statistical evaluation. Scale bars¼40
(a–o) and 10 (p–s) mm.
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Papilloma morphology of K10/ mice was indistin-
guishable from that of wild-type papillomas Once pap-
illomas had formed and developed into palpable tumors
their histological appearance was indistinguishable in both
genotypes. In papillomas, the wild-type showed an equally
strong induction of proliferation as the knockout (Fig 6a, b).
The unaltered proliferative state of the papillomas of the two
groups of mice was also reflected by the equal presence of
phospho-Rb positive cells (Fig 6c, d ).
Santos et al (2002) reported Akt expression throughout
the epidermis. In contrast, in Akt1 and Akt2 double-deficient
mice, the basal epidermal layer was most affected (Peng
et al, 2003). This is in line with our observation that the
expression of Akt kinase was restricted to the cells of the
basal and 1–2 spinous layers (Fig 6e, f ). Using antibodies
specific for Thr308- and Ser473-phosphorylated Akt kinase,
we found equal amounts of the activated kinase in wild-type
and K10/ mice (Fig 6i). Activin, a member of the trans-
forming growth factor (TGF)-b protein family, which is in-
volved in wound repair and epidermal morphogenesis
(Munz et al, 1999; Wankell et al, 2001) and is normally
present in the suprabasal layers of untreated epidermis (see
inset in Fig 6g), was completely absent in the papillomas of
both genotypes (Fig 6g, h). Whereas the unchallenged skin
of K10/ mice showed a clear increase in cyclin D1 and c-
Myc in comparison to the wild-type (Reichelt and Magin,
2002), in papillomas, the wild-type showed an equally
strong induction of these two proteins as the knockout
(Fig 7a, b and c, d respectively).
As judged by immunohistological analysis of the pap-
illomas, the expression pattern of keratins was equal in
wild-type and knockout mice, demonstrating typical differ-
entiation. For orientation, Fig 8a shows a section through a
typical arborizing papilloma in which the rectangle depicts a
representative site similar to those chosen for the following
immunofluorescence analysis with stroma in the middle and
epithelium on top and bottom. K1 expression was alto-
gether reduced and restricted to approximately 30% of the
epidermal cells, which displayed variable amounts of this
keratin (Fig 8b, c). Keratins K6 (Fig 8d, e), K16 (Fig 8f, g) and
K17 (data not shown), typical of alternative differentiation,
were equally induced in both genotypes. As we used an
antiserum that recognizes both K6a and K6b (Wojcik et al,
2000; Wong et al, 2000; Wojcik et al, 2001), we observed
staining throughout the epidermis. K17 showed an identical
distribution, whereas K16 was observed in suprabasal lay-
ers only. K4 (Fig 8h, i ) and K13 (Fig 8k, l ), which are normally
induced upon tumor formation, were found in both geno-
types at the same level.
Table II. Epidermal turnover
Time
BrdU-labeled nuclei/100 basal nuclei
Wild-type K10/
Basal Suprabasal Basal Suprabasal
2 h 2.7  1.5 0.0 22.9  4.6 0.7  1.0
1 d 4.9  2.0 0.3  0.6 42.6  13.4 23.3  16.3
3 d 10.3  4.3 0.9  1.9 39.6  10.3 95.4  18.3
5 d 6.3  2.9 2.5  2.1 22.1  6.6 73.9  23.3
7 d 5.2  3.1 2.1  2.4 10.7  3.0 43.0  15.7
9 d 3.9  2.1 1.3  1.2 5.2  3.0 29.7  13.4
18 d 2.7  1.9 2.3  1.3 0.0 0.0
Mice received one pulse of BrdU and were sacrificed at the given time
points thereafter. BrdU-labeled nuclei were counted in ear sections. 10–
20 areas of 100 basal cells were scored respectively, mean  SD are
given.
Figure4
Expression of cell adhesion molecules in interfollicular epidermis.
Immunofluorescence analysis of cell adhesion molecules revealed al-
terations in a6-integrin expression in K10
/epidermis (a, b). The wild-
type is depicted on the left, the knockout on the right. Arrows point to
punctate suprabasal a6-integrin staining in K10
/ epidermis (b) which
appeared in addition to the typical staining of the basal membrane of
basal keratinocytes. E-cadherin (c, d), b-catenin (e, f), desmoplakin (g,
h), plakoglobin (i, k) and plectin (l, m) were equally distributed in
both genotypes. Dotted lines indicate basement membrane. Scale
bar¼40 mm.
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Discussion
K10 is not necessary for the suppression of suprabasal
proliferation K10 is typically expressed in postmitotic, sup-
rabasal keratinocytes and is downregulated under condi-
tions of hyperproliferation, e.g., in wounds or in tumors
(Roop et al, 1988). This raised the question whether K10
might be actively involved in the inhibition of proliferation.
Ectopic transgene expression of K10 in the basal epidermis
supported this view as it resulted in the development of
a hypoplastic epidermis due to the suppression of prolifer-
ation (Santos et al, 2002). Additional cell transfection and
transgenic mouse studies led the authors to suggest that
K10 was able to inhibit cell cycle entry by sequestration of
Akt and protein kinase C (PKC)z in an Rb-dependent manner
(Paramio et al, 1999, 2001; Santos et al, 2002). Interestingly,
K10/ mice showed no increase in epidermal Akt activa-
tion, and although we observed hyperproliferation, this effect
remained restricted to the basal cell layer (herein, and Rei-
chelt and Magin, 2002). We conclude that the absence of
K10 in suprabasal cells triggered the proliferation of cells
residing in the neighboring basal compartment. These find-
ings are in agreement with the observed hyperproliferation in
patients suffering from epidermolytic hyperkeratosis who
carry mutations in K10 or K1 and show increased epidermal
proliferation (Frost et al, 1966). Here, we report the activation
of two branches of the MAPK pathway, namely ERK1/2 and
p38, as a consequence of the knockout which most likely
explains the hyperproliferation in K10/ mice. The activa-
tion of ERK, which reside in the basal cell layer (Takahashi
et al, 2002), is consistent with the increase in cyclin D1 and
c-Myc previously observed in K10/ epidermis (Reichelt
and Magin, 2002). ERK1/2 are involved in stimulating cyclin
D1 gene transcription (Marshall, 1999) and phosphorylation
by ERK can stabilize c-Myc (Sears et al, 2000). The restric-
tion of proliferating cells to the basal layer is consistent with
the strong suprabasal p38 activation in K10/ epidermis. It
has been shown that this MAPK is needed for G2 arrest after
ultraviolet radiation (Bulavin et al, 2001).
Accelerated epidermal cell turnover decreases tumor
susceptibility Papillomas of K10-deficient mice displayed
no changes in size, morphology or differentiation/prolifera-
tion state and their progression to squamous cell carcino-
mas was not altered in our experimental setting. This
indicated that once an initiated cell was determined to pro-
liferate autonomously, it developed into a tumor both in
wild-type and K10/ skin. Tracing BrdU-labeled keratin-
ocytes, we found that the epidermal cell turnover was highly
increased in K10/ mice, leading to an elimination of ini-
tiated keratinocytes. Finally, this causes a reduced number
of papillomas. The complete loss of label-retaining cells by
18 d after BrdU injection indicates that in K10/ mice,
transit amplifying (TA) cell fate is altered.
Reduced papilloma formation upon two-step skin car-
cinogenesis was also noted in transgenic mice overex-
pressing TGF-b1 (Cui et al, 1996) and the TGF-b superfamily
members bone morphogenetic protein (BMP)-4 and BMP-6
as well as in cyclooxygenase (COX)-1 and COX-2 knockout
mice (Blessing et al, 1995; Wach et al, 2001; Tiano et al,
2002). Similar to K10/ mice, COX-1- and COX-2-deficient
mice showed an accelerated transition time of keratin-
ocytes which was suggested to be responsible for the re-
duced papilloma formation in those mice (Tiano et al, 2002).
Like in K10/ mice, the decrease in epidermal tumorigen-
esis in COX-1 and COX-2 knockout mice was not accom-
panied by increased apoptosis (TUNEL assay data, not
shown). In BMP-4 transgenic animals, apoptosis, which is
normally very low in interfollicular epidermis, was increased
and suggested to be the reason for the reduced tumor for-
mation in those mice (Blessing et al, 1995).
In light of the increased transit as well as the increase in
K6 and K16, we previously observed in K10/ epidermis
(Reichelt and Magin, 2002), we infer that in vivo keratin-
ocytes of K10/ mice are more susceptable to mechanical
stress and more motile than those of wild-type animals. The
consecutive induction of K6, K16, and K17 in K10 null ep-
idermis/papillomas is in agreement with the pliability versus
resilience hypothesis, stating that K10 and K1 render cells
more stable and static whereas K6 and K16 confer enough
pliability for migration (Wong and Coulombe, 2003). In
agreement with the enhanced migration of K10/ keratin-
ocytes, punctate suprabasal a6-integrin staining was ob-
served. Subrabasal expression of integrins is associated
Figure 5
Activation of the MAP kinase pathway. (a) Western blot-
ting showed that total levels of ERK1/2 were identical
in wild-type and K10/ skin extracts, whereas a strong
increase in phosphorylated proteins was detected in the
K10/ sample. As for ERK, the overall expression of p38
was equal in both genotypes, whereas the activated phos-
phorylated form strongly predominated in the knockout.
Coomassie-stained blots on the right for loading control.
Immunofluorescence analysis, using a phospho-p38-spe-
cific antiserum, showed that the activated kinase was
localized in the differentiated suprabasal layers of K10/
epidermis (c), whereas wild-type epidermis showed no
activation of p38 (b), confirming the western blot data.
Dotted line indicates basement membrane. Scale bar¼
40 mm.
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with hyperproliferative conditions, like psoriasis. An induc-
tion of suprabasal b1- and b4-integrin was observed in
transgenic mice expressing inducible Raf or Ras in the ba-
sal epidermal layer and resulted in ERK1/2 activation
(Tarutani et al, 2003) and is in line with the observations in
K10/ mice.
In conclusion, our data present the first evidence that
absence of a keratin significantly reduces papilloma forma-
tion in mice. The in vivo data presented here do not support
a role of K10 as a proliferation inhibitor in normal epidermis.
The mechanism by which the loss of suprabasal K10 in-
duces proliferation of basal cells most likely does not in-
volve Akt kinase, but rather implies signaling mechanisms
leading to MAPK activation. The remarkable reduction in
papilloma formation and the accelerated keratinocyte tran-
sition through the epidermis as a result of K10 ablation, is
consistent with recent data on force-dependent changes in
the cytoskeleton. Under conditions of mechanical stress,
Rap1 was shown to enhance p38 MAPK (Sawada et al,
2001). Following stretching of keratinocytes, the activation
of ERK1/2 was shown to result in hyperproliferation and
altered keratin expression (Yano et al, 2004), possibly
through b1-integrin (Kippenberger et al, 2000). In light of
the different morphology and stability of intermediate
filaments formed between keratins K14/K5 and K14/K1 in-
stead of K10/K1 (Franke et al, 1983; Reichelt et al, 2001), it
is an attractive hypothesis that keratins may act as me-
chanotransducers.
Materials and Methods
Two-step experimental skin carcinogenesis For initiation-pro-
motion experiments, groups of 20 female 7-wk-old BALB/c wild-
type or K10/ mice (Reichelt et al, 2001) were initiated by a single
epicutaneous application of 0.1 mmol of DMBA (Sigma, Deisenho-
fen, Germany), dissolved in 0.1 mL of acetone. Beginning 1 wk
later, mice were treated each twice weekly with 0.1 mL of acetone
containing 5 nmol of TPA (Sigma) for 40 wk. The tumor incidence
(tumor bearers/survivors) and yield (number of tumors/survivors)
were recorded weekly (Furstenberger and Kopp-Schneider, 1995).
Tumors were identified first by visual inspection and later by his-
tological analysis. The Institutional Review Board has approved all
the performed animal studies.
Proliferation analysis with BrdU In order to analyze the prolif-
erative cutaneous response towards TPA, 6-wk-old wild-type and
K10/ mice were treated with 0.5 nmol TPA in 10 mL acetone on
the inner face of the left ear and with 0.25 nmol TPA in 10 mL
acetone on the inner face of the right ear. Experiments were done
Figure 6
Proliferation in papillomas and expression of Akt kinase. Ki-67
staining was comparable in tumors of wild-type and K10/ animals (a,
b). Expression of Ser780-phosphorylated Rb (c, d), Akt kinase (e, f) and
activin (g, inset shows activin in normal wild-type epidermis, h) were
unaltered in papillomas of K10/ mice. Wild-type on the left, K10/
on the right. Scale bar¼ 40 mm. Dotted lines indicate basement mem-
brane. Western blots revealed unchanged amounts of total Akt kinase,
Thr308-, and Ser473- phosphorylated Akt kinase in papilloma extracts
(i). Coomassie-stained blots on the right for loading control.
Figure7
Distribution of cyclin D1 and c-Myc in papillomas. Cyclin D1 (a, b)
and c-Myc (c, d) expression was observed by immunohistochemical
staining in the basal layers, whereas it was absent in the upper layers.
On the left, wild-type; right, K10/ tissue. Dotted lines indicate base-
ment membrane. Scale bar¼40 mm.
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in duplicates. Control animals received acetone on both ears. 18 or
24 h thereafter, mice were injected with 1ml BrdU per 100 g mouse
(10 mg per mL in 0.9% NaCl, Sigma) i.p. and were sacrificed 2 h
later. Ears were fixed in 4% formaldehyde. Paraffin sections were
rehydrated and antigen retrieval was performed using 10 mM so-
dium citrate buffer, pH 6 in the microwave oven for 20 min at
subboiling temperatures. Subsequently, sections were treated for
30 min with 2 N HCl at 371C followed by an incubation in 0.1%
trypsin (Sigma) at the same temperature. For antigen detection the
Super Sensitive Detection kit and AEC-solution (both BioGenex,
San Ramon, California) as a substrate for immunohistological de-
tection were used according to the manufacturer’s instructions.
Sections were counterstained with hematoxylin (Sigma).
For the analysis of the epidermal transit time, 20 mice were injected
with BrdU as described above and sacrificed at 24 h, 1, 3, 5, 7, 9, or
18 d thereafter, two mice at each time point. Ears and back skin were
fixed and BrdU-labeled nuclei were detected as described above.
Histology, immunoﬂuorescence and immunohistochemis-
try Papillomas were harvested 2 wk after the last TPA applica-
tion. For immunofluorescence analysis, tissues were snap-frozen in
liquid nitrogen. For histology and immunohistochemistry the pap-
illomas were fixed in freshly prepared 4% formaldehyde for 16 h
before embedding in paraffin. Histological sections of 6 mm were
stained with hematoxylin/eosin. Immunofluorescence was per-
formed as described before (Reichelt et al, 1999). Cryosections
were fixed in ice-cold acetone. For phospho-Rb and Akt, paraffin
sections were used after antigen retrieval for 25 min in 10 mM
sodium citrate buffer, pH 6 in the microwave oven (600 W). For
phospho-p38 MAPK retrieval, paraffin sections were heated for 10
min at 1201C in 0.1 M Tris/HCl at pH 9.5, 5% Urea. Antibodies and
antisera were diluted as follows: K1 antiserum AF109 (Babco,
Richmond, California), 1:5000; K6 antiserum (donated by Manfred
Blessing), 1:1000; K16 antiserum (donated by Rebecca Porter),
1:500; K4 antibody (6B10, Progen, Heidelberg, Germany), 1:10;
K13 antiserum (donated by Dennis Roop), 1:250; a6-integrin
antibody (GoH3, Progen), neat; E-cadherin antibody (ECCD-2,
Zymed, San Francisco, California), 1:500; b-catenin antibody
(clone 14, Transduction Laboratories, Lexington, Kentucky),
1:250; desmoplakin antibody (DP2.15, Progen, Heidelberg, Ger-
many), 1:20; plakoglobin antibody (11E4, donated by Werner
Franke), neat; plectin antibody (HD1, donated by Katsushi Owa-
ribe), 1:200; phospho(Ser780)-Rb antiserum (Cell Signaling Tech-
nology, Beverly, Massachusetts), 1:100; Akt antiserum (Cell
Signaling Technology), 1:20; phospho-p38 MAPK antiserum (Cell
Signaling Technology), 1:100; activin antiserum (donated by Sabine
Werner), 1:50. Secondary antisera were Cy3- and Cy2-conjugated
(Dianova, Hamburg, Germany). Immunohistochemistry: Ki-67
antiserum (Dianova, Hamburg, Germany), 1:50; cyclin D1 antibody
(DCS-6, Progen, Heidelberg, Germany), 1:10; c-Myc antibody (Ab-
3, Oncogene Science, Cambridge, MA, USA) 1:20. For detection,
the LSABþ kit (Dako, Hamburg, Germany) was used with DAB as
substrate. Sections were embedded with DPX (Sigma).
Western blotting Total skin protein was extracted, blotted and
stained as described before (Reichelt et al, 1999). Primary anti-
bodies were diluted as follows: Akt and phospho-Akt antisera
(Cell Signaling Technology), 1:2000; ERK1/2, phospho-ERK1/2,
p38, and phospho-p38 antisera (Cell Signaling Technology),
1:1000. Horseradish peroxidase-conjugated secondary antiserum
(Dianova, Hamburg, Germany) and Super Signal (Pierce, Rockford,
Illinois) were used for detection.
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Pohl-Arnold and Brigitte Steinbauer (DKFZ, Heidelberg) for excellent
technical assistance. For antisera gifts we thank Manfred Blessing
(Mainz, Germany), Werner Franke (Heidelberg, Germany), Katsushi
Owaribe (Nagoya, Japan), Rebecca Porter (Dundee, GB), Dennis Roop
(Houston, Texas, USA) and Sabine Werner (Zurich, Switzerland). This
Figure 8
Keratin expression in papillomas. (a) Hematoxylin/eosin-stained pap-
illoma. The rectangle shows a typical detail with stromal tissue in the
middle and epidermis on top and bottom. Comparable immunostained
sections of distinct keratins are shown in b–l, where the wild-type is on
the left and K10/ tissue on the right. The localization of K1 (b, c), K6
(d, e), K16 (f, g), K4 (h, i) and K13 (k, l) were equal in both genotypes.
Dotted lines indicate the basement membrane. Scale bars¼ 400 (a) and
40 (b–l) mm.
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